Arcadia Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting a beneficial ownership of 9.99% in Arcadia Biosciences, Inc.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 7.75% in Arcadia Biosciences, Inc., holding 159,390 shares as of March 31, 2026.
NASDAQ
Arcadia Biosciences, Inc. has disclosed a beneficial ownership of 5.08% in Above Food Ingredients Inc., holding 2,738,574 shares of common stock.
NASDAQ
Sabby Management, Sabby Volatility Warrant Master Fund, and Hal Mintz have reported a reduction in their passive beneficial ownership stake in Arcadia Biosciences, Inc. to 4.9% as of December 31, 2024.